Literature DB >> 18564390

Mixed-type autoimmune hemolytic anemia: differential diagnosis and a critical review of reported cases.

Beate Mayer1, Salih Yürek, Holger Kiesewetter, Abdulgabar Salama.   

Abstract

BACKGROUND: Autoimmune hemolytic anemia (AIHA) is usually classified as either warm or cold type. During the past few decades, mixed types (Mxs) have also been described in a number of cases (6%-8% of AIHA), often without serologic data to support the diagnosis. In this study, we demonstrate that the incidence of Mx AIHA in our institution is extremely rare. STUDY DESIGN AND METHODS: Between August 1998 and August 2007, all in- and outpatients with detectable warm autoantibodies (WABs) were included in this study. Serologic testing was performed using standard techniques for the detection of red blood cell antibodies.
RESULTS: From a total of 2194 patients with detectable WABs, only 2 patients (<0.1%) developed both WABs and cold agglutinins (CAs), which in the presence of clinical evidence of hemolytic anemia, satisfies the criteria for Mx AIHA. Only 1 of these patients, however, showed cold and warm hemolysis. Insignificant CAs at temperatures of not more than 24 degrees C were found in 242 patients.
CONCLUSION: There is evidence that the presence of CAs with high thermal amplitude and WABs may lead to confusion and misdiagnosis in some patients with AIHA. This study demonstrates that Mx AIHA is less common than previously reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564390     DOI: 10.1111/j.1537-2995.2008.01805.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  16 in total

1.  Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment.

Authors:  Quentin A Hill; Anita Hill; Sigbjørn Berentsen
Journal:  Blood Adv       Date:  2019-06-25

2.  The effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia.

Authors:  Abdulgabar Salama; Dirk Hartnack; Hans-Walter Lindemann; Hans-Joachim Lange; Mathias Rummel; Andreas Loew
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

3.  Look No Further: An Exercise in Clinical Reasoning.

Authors:  Patrick Rendon; Gurpreet Dhaliwal; Benjamin Kim; Alberto Aguayo; J Rush Pierce
Journal:  J Gen Intern Med       Date:  2016-04-13       Impact factor: 5.128

4.  Precautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimated.

Authors:  Salih Yürek; Beate Mayer; Mohammed Almahallawi; Axel Pruss; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2015-06-16       Impact factor: 3.443

5.  Autoimmune hemolytic anemia: mixed type-a case report.

Authors:  V R Sudha Reddy; Purnima Samayam; B Ravichander; Uma Bai
Journal:  Indian J Hematol Blood Transfus       Date:  2011-05-07       Impact factor: 0.900

Review 6.  [Autoimmune thrombocytopenia, neutropenia and hemolysis].

Authors:  A Greinacher; J Bux; A Salama
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

Review 7.  Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy.

Authors:  Sigbjørn Berentsen; Tatjana Sundic
Journal:  Biomed Res Int       Date:  2015-01-29       Impact factor: 3.411

8.  Harmless Pregnancy-Induced Warm Autoantibodies to Red Blood Cells.

Authors:  Gülüstan Sürücü; Beate Mayer; Anneliese Märzacker; Salih Yürek; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-09-10       Impact factor: 3.747

9.  Evidence Suggesting Complement Activation and Haemolysis at Core Temperature in Patients with Cold Autoimmune Haemolytic Anaemia.

Authors:  Thilo Bartolmäs; Salih Yürek; Abdelwahab Hassan Ahmed Balola; Beate Mayer; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-04       Impact factor: 3.747

10.  Variability of Findings in Drug-Induced Immune Haemolytic Anaemia: Experience over 20 Years in a Single Centre.

Authors:  Beate Mayer; Thilo Bartolmäs; Salih Yürek; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-09-09       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.